Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.

× No keyword cloud information.

12 in total

1. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.

Authors: Lisa Rigassi; Federica Barchiesi Bozzolo; Eliana Lucchinetti; Michael Zaugg; Jürgen Fingerle; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson; Raghvendra K Dubey
Journal: Am J Physiol Endocrinol Metab Date: 2015-10-20 Impact factor: 4.310

2. Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia.

Authors: Alexina Orsoni; Patrice Thérond; Ricardo Tan; Philippe Giral; Paul Robillard; Anatol Kontush; Peter J Meikle; M John Chapman
Journal: J Lipid Res Date: 2016-08-31 Impact factor: 5.922

3. LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL.

Authors: M John Chapman; Alexina Orsoni; Ricardo Tan; Natalie A Mellett; Anh Nguyen; Paul Robillard; Philippe Giral; Patrice Thérond; Peter J Meikle
Journal: J Lipid Res Date: 2020-04-15 Impact factor: 5.922

4. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.

Authors: Xian-sheng Huang; Shui-ping Zhao; Lin Bai; Min Hu; Wang Zhao; Qian Zhang
Journal: Br J Pharmacol Date: 2009-08-19 Impact factor: 8.739

Review 5. Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors: P V Luoma
Journal: Curr Mol Med Date: 2011-07 Impact factor: 2.222

6. Xanthine-based KMUP-1 improves HDL via PPARγ/SR-B1, LDL via LDLRs, and HSL via PKA/PKG for hepatic fat loss.

Authors: Kung-Kai Kuo; Bin-Nan Wu; Chung-Pin Liu; Tzu-Yang Yang; Li-Pin Kao; Jiunn-Ren Wu; Wen-Ter Lai; Ing-Jun Chen
Journal: J Lipid Res Date: 2015-09-08 Impact factor: 5.922

Review 7. Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors.

Authors: Mitsuru Shinohara; Naoyuki Sato; Munehisa Shimamura; Hitomi Kurinami; Toshimitsu Hamasaki; Amarnath Chatterjee; Hiromi Rakugi; Ryuichi Morishita
Journal: Front Aging Neurosci Date: 2014-04-23 Impact factor: 5.750

8. Statins: antimicrobial resistance breakers or makers?

Authors: Humphrey H T Ko; Ricky R Lareu; Brett R Dix; Jeffery D Hughes
Journal: PeerJ Date: 2017-10-24 Impact factor: 2.984

9. Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.

Authors: Belmiro Parada; Flávio Reis; Ângela Pinto; José Sereno; Maria Xavier-Cunha; Paula Neto; Petronila Rocha-Pereira; Alfredo Mota; Arnaldo Figueiredo; Frederico Teixeira
Journal: Int J Mol Sci Date: 2012-07-09 Impact factor: 6.208

10. Statins decrease leptin expression in human white adipocytes.

Authors: Prachi Singh; Yuebo Zhang; Pragya Sharma; Naima Covassin; Filip Soucek; Paul A Friedman; Virend K Somers
Journal: Physiol Rep Date: 2018-01